z-logo
Premium
[ 123 I]‐FP‐CIT‐SPECT demonstrates dopaminergic deficit in orthostatic tremor
Author(s) -
Katzenschlager Regina,
Costa Durval,
Gerschlager Willibald,
O'Sullivan John,
Zijlmans Jan,
Gacinovic Svetoslav,
Pirker Walter,
Wills Adrian,
Bhatia Kailash,
Lees Andrew J.,
Brown Peter
Publication year - 2003
Publication title -
annals of neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.764
H-Index - 296
eISSN - 1531-8249
pISSN - 0364-5134
DOI - 10.1002/ana.10475
Subject(s) - dopaminergic , dopamine transporter , putamen , parkinsonism , dopamine , parkinson's disease , caudate nucleus , medicine , orthostatic vital signs , levodopa , psychology , endocrinology , nuclear medicine , disease , blood pressure
There is increasing evidence of a potential role of the dopaminergic system in orthostatic tremor (OT): Association with parkinsonism and treatment effects of L‐dopa and dopamine agonists have been reported. Eleven patients with isolated OT had single‐photon emission computed tomography (SPECT) using 123 I‐FP‐CIT ([ 123 I]‐2β‐carbomethoxy‐3β‐(‐4‐iodophenyl)‐N‐(3‐fluoropropyl)‐nortropane) as dopamine transporter tracer. Results were compared with 12 age‐matched normal controls and 12 patients with Parkinson's disease (PD). A marked reduction in striatal tracer binding was found in OT compared to normal controls ( p < 0.001). Tracer uptake was significantly higher and more symmetrical than in PD, and caudate and putamen were equally affected. L‐dopa challenges, performed in seven patients, showed a small but non‐significant improvement on EMG and a small but significant improvement in clinical parameters on blinded video rating. Two‐month open‐label L‐dopa treatment (600 mg/day) led to a small improvement in two of five patients but no significant overall change. Olfactory function on University of Pennsylvania Smell Identification Test was normal. Our finding of a marked tracer uptake reduction on dopamine transporter SPECT supports a role of the dopaminergic system in OT. Lack of evidence of a clinically relevant therapeutic response to L‐dopa suggests that other mechanisms must also be involved in the pathogenesis. Ann Neurol 2003

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here